DOI record: { "DOI": "10.1038/s41598-025-34514-1", "ISSN": [ "2045-2322" ], "URL": "http://dx.doi.org/10.1038/s41598-025-34514-1", "alternative-id": [ "34514" ], "assertion": [ { "group": { "label": "Article History", "name": "ArticleHistory" }, "label": "Received", "name": "received", "order": 1, "value": "10 July 2025" }, { "group": { "label": "Article History", "name": "ArticleHistory" }, "label": "Accepted", "name": "accepted", "order": 2, "value": "29 December 2025" }, { "group": { "label": "Article History", "name": "ArticleHistory" }, "label": "First Online", "name": "first_online", "order": 3, "value": "26 February 2026" }, { "group": { "label": "Declarations", "name": "EthicsHeading" }, "name": "Ethics", "order": 1 }, { "group": { "label": "Competing interests", "name": "EthicsHeading" }, "name": "Ethics", "order": 2, "value": "The authors declare no competing interests." }, { "group": { "label": "Ethics approval and consent to participate", "name": "EthicsHeading" }, "name": "Ethics", "order": 3, "value": "This study was reviewed and approved by the Institutional Review Board of The First Affiliated Hospital of Zhengzhou University (2023-KY-0865-001). This study is retrospective, and no patient privacy information is exposed. Informed consent from the subject was not obtained." } ], "author": [ { "affiliation": [], "family": "Chen", "given": "Yu", "sequence": "first" }, { "affiliation": [], "family": "Li", "given": "Huan", "sequence": "additional" }, { "affiliation": [], "family": "Ma", "given": "Yichen", "sequence": "additional" }, { "affiliation": [], "family": "Wang", "given": "Ling", "sequence": "additional" }, { "affiliation": [], "family": "Qian", "given": "Guowu", "sequence": "additional" }, { "affiliation": [], "family": "Li", "given": "Silin", "sequence": "additional" }, { "affiliation": [], "family": "Luo", "given": "Hong", "sequence": "additional" }, { "affiliation": [], "family": "Zhang", "given": "Shixi", "sequence": "additional" }, { "affiliation": [], "family": "Li", "given": "Guangming", "sequence": "additional" }, { "affiliation": [], "family": "Zhang", "given": "Donghua", "sequence": "additional" }, { "affiliation": [], "family": "Li", "given": "Guotao", "sequence": "additional" }, { "affiliation": [], "family": "Zheng", "given": "Yun", "sequence": "additional" }, { "affiliation": [], "family": "Bai", "given": "Qin", "sequence": "additional" }, { "affiliation": [], "family": "Wang", "given": "Haiyu", "sequence": "additional" }, { "affiliation": [], "family": "Ren", "given": "Zhigang", "sequence": "additional" } ], "container-title": "Scientific Reports", "container-title-short": "Sci Rep", "content-domain": { "crossmark-restriction": false, "domain": [ "link.springer.com" ] }, "created": { "date-parts": [ [ 2026, 2, 26 ] ], "date-time": "2026-02-26T11:25:16Z", "timestamp": 1772105116000 }, "deposited": { "date-parts": [ [ 2026, 2, 26 ] ], "date-time": "2026-02-26T11:25:18Z", "timestamp": 1772105118000 }, "funder": [ { "award": [ "232102311084" ], "award-info": [ { "award-number": [ "232102311084" ] } ], "name": "the Medical Science and Technique Foundation of Henan Province, China" }, { "award": [ "242102310046" ], "award-info": [ { "award-number": [ "242102310046" ] } ], "name": "the Medical Science and Technique Foundation of Henan Province, China" }, { "award": [ "24B320034" ], "award-info": [ { "award-number": [ "24B320034" ] } ], "name": "Key Scientific Research Projects of Colleges and Universities in Henan Province" }, { "award": [ "2025ZD01906305" ], "award-info": [ { "award-number": [ "2025ZD01906305" ] } ], "name": "Prevention and Control of Emerging and Major Infectious Diseases-National Science and Technology Major Project" }, { "award": [ "ZYYC202301ZD" ], "award-info": [ { "award-number": [ "ZYYC202301ZD" ] } ], "name": "Henan Zhongyuan Medical Science and Technology Innovation and Development Foundation" }, { "award": [ "232300421124" ], "award-info": [ { "award-number": [ "232300421124" ] } ], "name": "the Natural Science Foundation Key Project of Henan Province" } ], "indexed": { "date-parts": [ [ 2026, 2, 26 ] ], "date-time": "2026-02-26T12:09:45Z", "timestamp": 1772107785734, "version": "3.50.1" }, "is-referenced-by-count": 0, "issued": { "date-parts": [ [ 2026, 2, 26 ] ] }, "language": "en", "license": [ { "URL": "https://creativecommons.org/licenses/by-nc-nd/4.0", "content-version": "tdm", "delay-in-days": 0, "start": { "date-parts": [ [ 2026, 2, 26 ] ], "date-time": "2026-02-26T00:00:00Z", "timestamp": 1772064000000 } }, { "URL": "https://creativecommons.org/licenses/by-nc-nd/4.0", "content-version": "am", "delay-in-days": 0, "start": { "date-parts": [ [ 2026, 2, 26 ] ], "date-time": "2026-02-26T00:00:00Z", "timestamp": 1772064000000 } } ], "link": [ { "URL": "https://www.nature.com/articles/s41598-025-34514-1", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining" } ], "member": "297", "original-title": [], "prefix": "10.1038", "published": { "date-parts": [ [ 2026, 2, 26 ] ] }, "published-online": { "date-parts": [ [ 2026, 2, 26 ] ] }, "publisher": "Springer Science and Business Media LLC", "reference": [ { "key": "34514_CR1", "unstructured": "WHO. WHO COVID-19 dashboard. https://data.who.int/dashboards/covid19/cases?n=c (2024)." }, { "DOI": "10.1136/bmj.m1985", "author": "AB Docherty", "doi-asserted-by": "publisher", "journal-title": "BMJ", "key": "34514_CR2", "unstructured": "Docherty, A. B. et al. Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO clinical characterisation protocol: Prospective observational cohort study. BMJ 369, m1985. https://doi.org/10.1136/bmj.m1985 (2020).", "volume": "369", "year": "2020" }, { "DOI": "10.1016/s0140-6736(20)30566-3", "author": "F Zhou", "doi-asserted-by": "publisher", "first-page": "1054", "journal-title": "Lancet", "key": "34514_CR3", "unstructured": "Zhou, F. et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study. Lancet 395, 1054–1062. https://doi.org/10.1016/s0140-6736(20)30566-3 (2020).", "volume": "395", "year": "2020" }, { "DOI": "10.1038/s41421-020-00235-0", "author": "LK Zhang", "doi-asserted-by": "publisher", "first-page": "96", "journal-title": "Cell. Discov.", "key": "34514_CR4", "unstructured": "Zhang, L. K. et al. Calcium channel blocker amlodipine besylate therapy is associated with reduced case fatality rate of COVID-19 patients with hypertension. Cell. Discov. 6, 96. https://doi.org/10.1038/s41421-020-00235-0 (2020).", "volume": "6", "year": "2020" }, { "DOI": "10.1001/jama.2016.19043", "author": "MH Forouzanfar", "doi-asserted-by": "publisher", "first-page": "165", "journal-title": "JAMA", "key": "34514_CR5", "unstructured": "Forouzanfar, M. H. et al. Global burden of hypertension and systolic blood pressure of at least 110 to 115 mm Hg, 1990–2015. JAMA 317, 165–182. https://doi.org/10.1001/jama.2016.19043 (2017).", "volume": "317", "year": "2017" }, { "DOI": "10.1080/07853890.2021.1931957", "author": "L Zhong", "doi-asserted-by": "publisher", "first-page": "770", "journal-title": "Ann. Med.", "key": "34514_CR6", "unstructured": "Zhong, L. et al. Effects of hypertension on the outcomes of COVID-19: a multicentre retrospective cohort study. Ann. Med. 53, 770–776. https://doi.org/10.1080/07853890.2021.1931957 (2021).", "volume": "53", "year": "2021" }, { "DOI": "10.1038/s41440-020-0485-2", "author": "S Huang", "doi-asserted-by": "publisher", "first-page": "824", "journal-title": "Hypertens. Res.", "key": "34514_CR7", "unstructured": "Huang, S. et al. COVID-19 patients with hypertension have more severe disease: A multicenter retrospective observational study. Hypertens. Res. 43, 824–831. https://doi.org/10.1038/s41440-020-0485-2 (2020).", "volume": "43", "year": "2020" }, { "DOI": "10.1080/10641963.2022.2071914", "author": "Z Qian", "doi-asserted-by": "publisher", "first-page": "451", "journal-title": "Clin. Exp. Hypertens.", "key": "34514_CR8", "unstructured": "Qian, Z. et al. Association between hypertension and prognosis of patients with COVID-19: A systematic review and meta-analysis. Clin. Exp. Hypertens. 44, 451–458. https://doi.org/10.1080/10641963.2022.2071914 (2022).", "volume": "44", "year": "2022" }, { "DOI": "10.1038/s41579-020-00468-6", "author": "P V’Kovski", "doi-asserted-by": "publisher", "first-page": "155", "journal-title": "Nat. Rev. Microbiol.", "key": "34514_CR9", "unstructured": "V’Kovski, P., Kratzel, A., Steiner, S., Stalder, H. & Thiel, V. Coronavirus biology and replication: implications for SARS-CoV-2. Nat. Rev. Microbiol. 19, 155–170. https://doi.org/10.1038/s41579-020-00468-6 (2021).", "volume": "19", "year": "2021" }, { "DOI": "10.1093/cid/ciad032", "author": "MK Hayden", "doi-asserted-by": "publisher", "first-page": "e350", "journal-title": "Clin. Infect. Dis.", "key": "34514_CR10", "unstructured": "Hayden, M. K. et al. The infectious diseases society of America guidelines on the diagnosis of COVID-19: Antigen testing (January 2023). Clin. Infect. Dis. 78, e350–e384. https://doi.org/10.1093/cid/ciad032 (2024).", "volume": "78", "year": "2024" }, { "DOI": "10.1056/NEJMoa2118542", "author": "J Hammond", "doi-asserted-by": "publisher", "first-page": "1397", "journal-title": "N. Engl. J. Med.", "key": "34514_CR11", "unstructured": "Hammond, J. et al. Oral nirmatrelvir for high-risk, nonhospitalized adults with COVID-19. N. Engl. J. Med. 386, 1397–1408. https://doi.org/10.1056/NEJMoa2118542 (2022).", "volume": "386", "year": "2022" }, { "DOI": "10.1056/NEJMoa2116044", "author": "A Jayk Bernal", "doi-asserted-by": "publisher", "first-page": "509", "journal-title": "N. Engl. J. Med.", "key": "34514_CR12", "unstructured": "Jayk Bernal, A. et al. Molnupiravir for oral treatment of COVID-19 in nonhospitalized patients. N. Engl. J. Med. 386, 509–520. https://doi.org/10.1056/NEJMoa2116044 (2022).", "volume": "386", "year": "2022" }, { "DOI": "10.1016/j.xinn.2022.100321", "author": "B Yu", "doi-asserted-by": "publisher", "first-page": "100321", "journal-title": "Innov. Camb. Mass.", "key": "34514_CR13", "unstructured": "Yu, B. & Chang, J. The first Chinese oral anti-COVID-19 drug Azvudine launched. Innov. Camb. Mass. 3, 100321. https://doi.org/10.1016/j.xinn.2022.100321 (2022).", "volume": "3", "year": "2022" }, { "key": "34514_CR14", "unstructured": "Cascella, M., Rajnik, M., Aleem, A., Dulebohn, S. C. & Di Napoli, R. In StatPearls (StatPearls Publishing Copyright © 2025, StatPearls Publishing LLC., 2025)" }, { "DOI": "10.1016/s0140-6736(22)01586-0", "author": "CKH Wong", "doi-asserted-by": "publisher", "first-page": "1213", "journal-title": "Lancet", "key": "34514_CR15", "unstructured": "Wong, C. K. H. et al. Real-world effectiveness of molnupiravir and nirmatrelvir plus ritonavir against mortality, hospitalisation, and in-hospital outcomes among community-dwelling, ambulatory patients with confirmed SARS-CoV-2 infection during the omicron wave in Hong Kong: an observational study. Lancet 400, 1213–1222. https://doi.org/10.1016/s0140-6736(22)01586-0 (2022).", "volume": "400", "year": "2022" }, { "DOI": "10.1016/j.lanwpc.2022.100602", "author": "AK Wai", "doi-asserted-by": "publisher", "journal-title": "Lancet Reg. Health West Pac.", "key": "34514_CR16", "unstructured": "Wai, A. K. et al. Association of Molnupiravir and Nirmatrelvir-Ritonavir with preventable mortality, hospital admissions and related avoidable healthcare system cost among high-risk patients with mild to moderate COVID-19. Lancet Reg. Health West Pac. 30, 100602. https://doi.org/10.1016/j.lanwpc.2022.100602 (2023).", "volume": "30", "year": "2023" }, { "DOI": "10.1007/s40121-023-00760-x", "author": "C Weng", "doi-asserted-by": "publisher", "first-page": "649", "journal-title": "Infect. Dis. Ther.", "key": "34514_CR17", "unstructured": "Weng, C. et al. Safety and efficacy of paxlovid against omicron variants of coronavirus disease 2019 in elderly patients. Infect. Dis. Ther. 12, 649–662. https://doi.org/10.1007/s40121-023-00760-x (2023).", "volume": "12", "year": "2023" }, { "DOI": "10.1038/s41392-021-00835-6", "author": "JL Zhang", "doi-asserted-by": "publisher", "first-page": "414", "journal-title": "Signal Transduct. Target Ther.", "key": "34514_CR18", "unstructured": "Zhang, J. L. et al. Azvudine is a thymus-homing anti-SARS-CoV-2 drug effective in treating COVID-19 patients. Signal Transduct. Target Ther. 6, 414. https://doi.org/10.1038/s41392-021-00835-6 (2021).", "volume": "6", "year": "2021" }, { "key": "34514_CR19", "unstructured": "ADMINISTRATION, N. M. P. Domestically developed drug joins virus battle. http://english.nmpa.gov.cn/2022-08/15/c_797867.htm (2022)." }, { "DOI": "10.1002/advs.202001435", "author": "Z Ren", "doi-asserted-by": "publisher", "first-page": "e2001435", "journal-title": "Adv. Sci.", "key": "34514_CR20", "unstructured": "Ren, Z. et al. A randomized, open-label, controlled clinical trial of azvudine tablets in the treatment of mild and common COVID-19, a pilot study. Adv. Sci. 7, e2001435. https://doi.org/10.1002/advs.202001435 (2020).", "volume": "7", "year": "2020" }, { "DOI": "10.1038/s41392-025-02126-w", "author": "H Wang", "doi-asserted-by": "publisher", "first-page": "30", "journal-title": "Signal Transduct. Target. Ther.", "key": "34514_CR21", "unstructured": "Wang, H. et al. Real-world effectiveness and safety of oral azvudine versus nirmatrelvir-ritonavir (Paxlovid) in hospitalized patients with COVID-19: A multicenter, retrospective, cohort study. Signal Transduct. Target. Ther. 10, 30. https://doi.org/10.1038/s41392-025-02126-w (2025).", "volume": "10", "year": "2025" }, { "DOI": "10.1002/advs.202404450", "author": "R Sun", "doi-asserted-by": "publisher", "first-page": "e2404450", "journal-title": "Adv. Sci.", "key": "34514_CR22", "unstructured": "Sun, R. et al. Effectiveness and safety of oral azvudine for elderly hospitalized patients with COVID-19: A multicenter, retrospective, real-world study. Adv. Sci. 12, e2404450. https://doi.org/10.1002/advs.202404450 (2025).", "volume": "12", "year": "2025" }, { "DOI": "10.1016/j.isci.2025.111907", "author": "G Su", "doi-asserted-by": "publisher", "first-page": "111907", "journal-title": "iScience", "key": "34514_CR23", "unstructured": "Su, G. et al. Real-world effectiveness of azvudine versus nirmatrelvir-ritonavir in hospitalized patients with COVID-19 and pre-existing diabetes. iScience 28, 111907. https://doi.org/10.1016/j.isci.2025.111907 (2025).", "volume": "28", "year": "2025" }, { "key": "34514_CR24", "unstructured": "China, N. H. C. o. t. P. s. R. o. COVID-19 diagnosis and treatment plan (trial version 9). https://www.gov.cn/zhengce/zhengceku/2022-03/15/5679257/files/49854a49c7004f4ea9e622f3f2c568d8.pdf (2022)." }, { "key": "34514_CR25", "unstructured": "China, N. H. C. o. t. P. s. R. o. COVID-19 Diagnosis and treatment plan (trial version 10). https://www.gov.cn/zhengce/zhengceku/2023-01/06/5735343/files/5844ce04246b431dbd322d8ba10afb48.pdf (2023)." }, { "key": "34514_CR26", "unstructured": "Services, U. S. D. O. H. A. H. Common Terminology Criteria for Adverse Events (CTCAE) Version 5.0. https://ctep.cancer.gov/protocoldevelopment/electronic_applications/docs/ctcae_v5_quick_reference_5x7.pdf (2017)." }, { "DOI": "10.1016/j.jinf.2024.106355", "author": "Z Ren", "doi-asserted-by": "publisher", "journal-title": "J. Infect.", "key": "34514_CR27", "unstructured": "Ren, Z. et al. Real-world effectiveness and safety of azvudine in hospitalized patients with SARS-CoV-2 infection: A multicenter, retrospective cohort study. J. Infect. 89, 106355. https://doi.org/10.1016/j.jinf.2024.106355 (2024).", "volume": "89", "year": "2024" }, { "DOI": "10.3389/fendo.2025.1467303", "author": "Y Zhou", "doi-asserted-by": "publisher", "first-page": "1467303", "journal-title": "Front. Endocrinol.", "key": "34514_CR28", "unstructured": "Zhou, Y. et al. A multicenter, real-world cohort study: effectiveness and safety of Azvudine in hospitalized COVID-19 patients with pre-existing diabetes. Front. Endocrinol. 16, 1467303. https://doi.org/10.3389/fendo.2025.1467303 (2025).", "volume": "16", "year": "2025" }, { "DOI": "10.1002/advs.202405679", "author": "J Sun", "doi-asserted-by": "publisher", "first-page": "e2405679", "journal-title": "Adv. Sci.", "key": "34514_CR29", "unstructured": "Sun, J. et al. The antiviral efficacy and safety of azvudine in hospitalized SARS-CoV-2 infected patients with liver diseases based on a multicenter, retrospective cohort study. Adv. Sci. 12, e2405679. https://doi.org/10.1002/advs.202405679 (2025).", "volume": "12", "year": "2025" }, { "DOI": "10.1186/s12879-025-10643-w", "author": "B Rao", "doi-asserted-by": "publisher", "first-page": "275", "journal-title": "BMC Infect. Dis.", "key": "34514_CR30", "unstructured": "Rao, B. et al. Real-world effectiveness and safety of oral azvudine versus paxlovid for COVID-19 in patients with kidney disease: A multicenter, retrospective, cohort study. BMC Infect. Dis. 25, 275. https://doi.org/10.1186/s12879-025-10643-w (2025).", "volume": "25", "year": "2025" }, { "DOI": "10.1002/advs.202306050", "author": "L Wu", "doi-asserted-by": "publisher", "first-page": "e2306050", "journal-title": "Adv. Sci.", "key": "34514_CR31", "unstructured": "Wu, L. et al. Azvudine for the treatment of COVID-19 in pre-existing cardiovascular diseases: A single-center, real-world experience. Adv. Sci. 11, e2306050. https://doi.org/10.1002/advs.202306050 (2024).", "volume": "11", "year": "2024" }, { "DOI": "10.1056/NEJMoa2001282", "author": "B Cao", "doi-asserted-by": "publisher", "first-page": "1787", "journal-title": "N. Engl. J. Med.", "key": "34514_CR32", "unstructured": "Cao, B. et al. A trial of lopinavir-ritonavir in adults hospitalized with severe COVID-19. N. Engl. J. Med. 382, 1787–1799. https://doi.org/10.1056/NEJMoa2001282 (2020).", "volume": "382", "year": "2020" }, { "DOI": "10.1056/NEJMoa2021436", "author": "P Horby", "doi-asserted-by": "publisher", "first-page": "693", "journal-title": "N. Engl. J. Med.", "key": "34514_CR33", "unstructured": "Horby, P. et al. Dexamethasone in hospitalized patients with COVID-19. N. Engl. J. Med. 384, 693–704. https://doi.org/10.1056/NEJMoa2021436 (2021).", "volume": "384", "year": "2021" }, { "DOI": "10.3389/fmed.2023.1143485", "author": "RM da Silva", "doi-asserted-by": "publisher", "first-page": "1143485", "journal-title": "Front. Med.", "key": "34514_CR34", "unstructured": "da Silva, R. M. et al. Serial viral load analysis by DDPCR to evaluate FNC efficacy and safety in the treatment of mild cases of COVID-19. Front. Med. 10, 1143485. https://doi.org/10.3389/fmed.2023.1143485 (2023).", "volume": "10", "year": "2023" } ], "reference-count": 34, "references-count": 34, "relation": {}, "resource": { "primary": { "URL": "https://www.nature.com/articles/s41598-025-34514-1" } }, "score": 1, "short-title": [], "source": "Crossref", "subject": [], "subtitle": [], "title": "Evaluating the effectiveness and safety of Azvudine for hospitalised patients with COVID-19 and hypertension: a multicenter retrospective cohort study", "type": "journal-article", "update-policy": "https://doi.org/10.1007/springer_crossmark_policy" }